Densitas intelliMammo provides the tools to deliver personalized measures of breast density, breast cancer risk, and clinical image quality that can be used to develop unbiased, tailored screening protocols for every woman every time she has a mammogram.
– Dr. Georgia SpearChief Breast Imaging, NorthShore University HealthSystem
Densitas intelliMammo played an essential role in ACR accreditation and MQSA EQUIP preparations and compliance at our clients' facilities. It allowed us to identify high-quality mammograms in a matter of minutes instead of days and automatically provided a comprehensive EQUIP report that is otherwise impossible to generate. Densitas intelliMammo is a must for breast imaging facilities.
– Dr. Martha GarrisonTeleMammography Specialists
Using the Densitas intelliMammo analytics platform and artificial intelligence algorithms to delineate your mammography image quality, means information now, action now, and improvement now.
A.I.-powered analytics for mammography facilities is a game-changer. The intelliMammo platform provides on-demand information on specific positioning criteria that allows targeted areas of improvement to be dealt with immediately, not after months of suboptimal quality. We can now systematically compare quality indicators and set benchmarks for performance in a way that has never been possible
– Stephanie SchofieldQuality Control Technologist, Diagnostic Imaging, NSH
I am intrigued by the broader approach that Densitas software suite has taken to not only provide density analysis but also to evaluate overall image quality and provide personalized breast cancer risk assessment. This more comprehensive integration into the overall workflow of image acquisition, image evaluation, and decision support represents the future of A.I. in a variety of different clinical domains.
– Dr. Eliot Siegel Professor and Vice-Chair at the University of Maryland School of Medicine, Department of Diagnostic Radiology, and Chief of Radiology and Nuclear Medicine for the Veterans Affairs Maryland Healthcare System.
Our experience is that intelliMammo densityai helps us provide a rapid, reproducible, and standardized way to report breast density across our health system so that a woman gets consistent results, whether she goes to two different clinics or her mammogram is read by different radiologists.
– Dr. Sian IlesSection Head for Breast Imaging Nova Scotia Health; Central Zone
IntelliMammo has enabled us to remotely monitor and manage mammography quality using standardized and objective positioning criteria. Since the adoption of intelliMammo we’ve seen significant improvement in technologists’ positioning performance and increased confidence in reaching out for feedback to address the challenges they are experiencing with their technique.
– Dr. Jamie SurrattDirector, RAD-AID International
HALIFAX, NS, May 12, 2022 /CNW/ – Densitas® Inc., a global provider of A.I. technologies for digital mammography and breast screening announced an expansion of their partnership agreement with Blackford to integrate more of Densitas®’ solutions with the Blackford Platform. “Expanding our partnership with Blackford is a natural progression to support scaling the growth of our breast cancer risk and image quality […]
HALIFAX, NS, Nov. 29, 2021 /PRNewswire/ – Densitas® Inc., a global provider of A.I. technologies for digital mammography and breast screening, named Alexandra Bade Director, Global Sales and Operations to lead the company’s global market expansion. “I am thrilled to join the team at a time when we have the opportunity to make a big impact on improving quality and outcomes for […]
HALIFAX, NS, Oct. 28, 2021 /CNW/ – Densitas® Inc., a global provider of A.I. technologies for digital mammography and breast screening, signed an agreement with RAD-AID International to deploy densitas® intellMammo™ A.I. software platform at Georgetown Public Hospital (GPHC) in Guyana. The age-adjusted breast cancer death rate in Guyana for 2018 was 24.36 per 100,000 women, compared to 17.49 in […]